Are Things Looking Up For Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL)?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Zentalis Pharmaceuticals Inc is $300.37M. A total of 1.25 million shares were traded on the day, compared to an average of 1.38M shares.

In the most recent transaction, Gallagher Cam sold 9,597 shares of ZNTL for 11.98 per share on May 31 ’24. After the transaction, the President, Interim CFO now owns 633,680 company shares. In a previous transaction on May 09 ’24, HAUSMAN DIANA sold 3,356 shares at 12.62 per share. ZNTL shares that Chief Medical Officer owns now total 373,876.

Among the insiders who sold shares, Epperly Melissa B, disposed of 2,573 shares on Feb 12 ’24 at a per-share price of $11.44. This resulted in the Chief Financial Officer holding 451,449 shares of ZNTL after the transaction. In another insider transaction, Gallagher Cam sold 1,173 shares at $11.44 per share on Feb 12 ’24. Company shares held by the President now total 643,277.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, ZNTL has a high of $29.03 and a low of $3.27.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ZNTL’s latest balance sheet shows that the firm has $339.89M in Cash & Short Term Investments as of fiscal 2021. There were $44.46M in debt and $43.94M in liabilities at the time. Its Book Value Per Share was $6.46, while its Total Shareholder’s Equity was $364.48M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZNTL is Buy with a score of 3.73.

Most Popular

Related Posts